| |
Faculty-to-Faculty
Associate IGB Director, G. Wesley Hatfield and IGB
Structural Genomics Program Leader, Richard Lathrop exemplify a
productive IGB cross-discipline research partnership. Hatfield,
Professor of Microbiology & Molecular Genetics, and Lathrop, Assoc.
Professor of Computer Science, have patented a technology
to produce synthetic genes. Previously seed funded by IGB, this
work is currently being funded by a UC BREP grant and a recently
awarded $1.5 M NSF Information and Technology Research (ITR) grant.
This project has already benefited researchers in several other
life science disciplines, and has led to other synergistic collaborations,
including plans for a new IGB/UCI core facility.
Multiple Institution
IGB and the UCI Center for Virus Research (CVR),
under the leadership of IGB member Luis Villarreal, have collaborated
on a major bioterrorism project. The core technology for this project
derives from IGB-seeded faculty-to-faculty research. The project,
recently awarded a $1.25 M five-year NIH grant, seeks to produce
genes for in vitro protein synthesis to be used to screen
infected patient sera for bacterial antigens that might be useful
for vaccines, and to identify efficacious drug targets.
IGB Systems Biology Program Leader, Eric Mjolsness, together with
other IGB members, collaborators at the California Institute of
Technology (Caltech), and the Jet Propulsion Laboratory (JPL), have led a major
multi-investigator effort in Systems Biology that has also been
recognized by major funding.
IGB—Industry
Since its inception, the Institute has had close
ties with Sun Microsystems. Recently, Director Pierre Baldi and
other IGB researchers were awarded an NSF Major Research Instrumentation
grant on which Sun Microsystems and other technology vendors collaborated.
Illumina, Inc., recently participated in
and supported the IGB-hosted 2003 Southern California Biotechnology
Symposium.
|
|